Chu Montpellier Hopital Arnaud de Villeneuve

Montpellier 34295 CEDEX

1 studies enrolling now · 3 studies all time

What they study most

Heart Failure, Non-Small Cell Lung Cancer, Symptomatic Hypertrophic Cardiomyopathy (HCM)

Studies at this site

• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• Benefits of Microcor in Ambulatory Decompensated Heart Failure — Completed